Supreme Court Turns Down Athena v. Allergan; 'Torrent' Of Suits To Come?
• By Lauren Nardella
Following the recommendation of Solicitor General Donald Verrilli, the Supreme Court has declined to review Allergan v. Athena Cosmetics, a case examining if the Federal Food, Drug and Cosmetic Act preempts an unfair competition claim in California characterizing Athena's RevitaLash products as unapproved drugs. Athena predicts a "torrent of novel and disruptive litigation" could ensue.
Courts may have a larger role in determining if a product should be regulated as a cosmetic or a drug following the Supreme Court's refusal to hear Athena Cosmetics, Inc. v. Allergan, Inc.
Athena's was one of numerous
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
